Notice Number: NOT-AR-14-019
Key Dates
Release Date: April 2, 2014
RFA-AR-14-015
RFA-AR-14-016
Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Allergy and Infectious Diseases (NIAID)
Purpose
On March 21, 2014, NIH issued the Funding Opportunity Announcements (FOA) RFA-AR-14-015 "Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)" and RFA-AR-14-016 "Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)".
An Applicant Information Webinar will be held on April 9, 2014, from 3:00 p.m. to 4:30 p.m. (Eastern Daylight Time) to provide information about these FOAs to assist prospective applicants. NIH staff will provide an overview of the FOAs and the review process, and answer questions. The webinar is open to all prospective applicants, but participation in the webinar is not a prerequisite to applying. Information about how to participate in the webinar can be found at: http://www.niams.nih.gov/Funding/Funded_Research/AMP_RA_Lupus/. Afterwards, the webinar slides will be posted to the same site.
Inquiries
Please direct all inquiries to:
Su-Yau Mao, Ph.D.
National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: AMPRALupus@mail.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: AMPRALupus@mail.nih.gov
and Human Services (HHS)
